Yahoo Web Search

Search results

1. www.regeneron.comRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

   www.regeneron.com

   • Cached

   Regeneron is a biotech company that develops new medicines for serious diseases using novel technologies and scientific innovation. Learn about its history, research areas, clinical trials, responsibility goals, and career opportunities.

   • Career Opportunities

     Working at Regeneron We are a team of original thinkers who...

   • Approved Medicines

     Regeneron (NASDAQ: REGN) is a leading biotechnology company...

   • Locations & Contact

     Medical Inquiries for all other Regeneron Products, please...

   • Investigational Pipeline

     UPDATE: Due to the high circulation of the SARS-CoV-2...

   • Leadership

     Leonard (Len) Brooks joined Regeneron in 2013 and serves as...

   • About

     At Regeneron, we move science to medicine because our world...

   • Investor Relations

     The Investor Relations website contains information about...

   • Scientists

     Rapid response to infectious diseases. How can we go even...

2. en.wikipedia.org › wiki › Regeneron_PharmaceuticalsRegeneron Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Regeneron_Pharmaceuticals

   • Cached

   Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

3. Images

   • 
   • 
   • 
   • 

   View all

4. www.regeneron.com › aboutAbout Regeneron Pharmaceuticals: Innovative Biotechnology

   www.regeneron.com › about

   • Cached

   Regeneron is a biotech company that invents and develops drugs for various diseases, such as eye, allergic, cancer, cardiovascular and neurological conditions. Founded and led by physician-scientists, Regeneron uses proprietary technologies, genetic insights and data-powered approaches to advance science and medicine.

5. www.regeneron.com › globalRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

   www.regeneron.com › global

   • Cached

   Regeneron invents, develops and commercializes treatments for serious diseases, such as eye, allergic, inflammatory, cancer, cardiovascular, neurological and rare diseases. Regeneron uses proprietary technologies, genetic medicine platforms and data-powered insights to push the bounds of science and improve patients' lives.

6. Videos

   • 

     8:51

     youtube.com

     The Rise of Regeneron Pharmaceuticals: Exploring the Company's Success Factors and Stock Valuation

     15 Jun 2023

     451 Views

   • 

     10:35

     youtube.com

     Regeneron Pharmaceuticals: Finding Stock Market Winners

     7 Feb 2024

     59 Views

   • 

     1:59

     youtube.com

     How Biotech Company Regeneron Flipped The Script In Drug Development | IBD

     9 May 2022

     1.5K Views

   View all

7. Top Stories

   • 

     Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day

     Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

     MarketWatch

     7 hours ago

   • 

     Zacks.com on MSN.com

     Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?

     2 days ago

   • 

     MarketWatch

     Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gains

     1 day ago

   • 

     Reuters

     Court weighs what US must prove in Regeneron kickback case

     3 days ago

   • FiercePharma

     Amid Eylea clash, Roche's Vabysmo keeps climbing despite a slowdown in its momentum

     16 hours ago

   View all

8. investor.regeneron.com › press-releasesPress Releases | Regeneron Pharmaceuticals Inc.

   investor.regeneron.com › press-releases

   • Cached

   Find the latest news and updates from Regeneron, a biotechnology company developing and commercializing medicines for serious diseases. See the list of press releases from 2015 to 2024, including approvals, data, and events.

9. investor.regeneron.comInvestor Relations | Regeneron Pharmaceuticals Inc.

   investor.regeneron.com

   • Cached

   3 days ago · The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

10. newsroom.regeneron.com › news-releases › news-release-detailsINVESTORS & MEDIA - Regeneron Pharmaceuticals Inc.

    newsroom.regeneron.com › news-releases › news-release-details

    • Cached

    Jul 30, 2021 · Regeneron announces FDA expanded authorization of REGEN-COV™, a COVID-19 antibody cocktail, for post-exposure prophylaxis in certain high-risk people. REGEN-COV is the only antibody therapy available for both treatment and prevention of COVID-19 in the U.S.